Armenicum

Key points
- Armenicum is an anti-HIV therapy currently being studied in Armenia and other countries from the former Soviet Union.
- In the late 1980's, a group of Armenian medical researchers and scientists in YEREVAN City engaged themselves in AIDS-related studies.
- Armenicum is a new composite medication with promising antiviral, antibacterial and immunomodulating properties.
- The product is supposed to have been developed as part of an anti-germ/chemical warfare inoculation for Soviet troops.
Armenicum - a drug invented by Armenian scientist to treat AIDS
Armenicum is an anti-HIV therapy currently being studied in Armenia and other countries from the former Soviet Union. The product is supposed to have been developed as part of an anti-germ/chemical warfare inoculation for Soviet troops.
Armenicum is an anti-viral, anti-bacterial and immune- stimulating drug which fights HIV and a number of associated diseases. Treatment by Armenicum is considered to be a monotherapy not including other anti-HIV drugs in treatment complex.
The drug "Armenicum" isn't a mechanical mixture of starting ingredients determined in the finished product of their synthesis, but a compound multicomponent complex of dextrin (mixture of mono-, oligo-, polysaccharides) and polyvinyl alcohol with the molecules of iodine, iodide anions, sodium, potassium and lithium cations and chloride anions, being in dynamic balance state which is changed depending on pH and concentration (dilution) of the drug solution.
Total quantity of iodide anion at definite concentrations and pH of the solution differs from the quantity of iodide anion formed in the result of potassium iodide dissociation.
Besides, iodide anion is being formed in the result of molecular iodine hydrolysis and thereafter it forms complexes
Armenicum completely remedies all virus diseases, in particular, hepatitis C. Many wonder if Armenicum cures cancer? Unfortunately, it does not, but Armenian scientists are making some research in this direction as well.
How things started
In the late 1980's, a group of Armenian medical researchers and scientists in YEREVAN City engaged themselves in AIDS-related studies. Happily, their work was eventually crowned with success. They created a preparation, named Armenicum, removing HIV virus from human blood and restoring man's immune system. Doubtless, before being officially announced, the preparation had undergone a series of laboratory tests. Initially, it was applied on animals only, but afterwards one of the group members applied the drug on himself. It was only in the autumn of 1998 that the drug started to be applied in Armenia. The discovery of the drug was announced worldwide in February 1999, after which Armenian clinics started to receive AIDS patients from abroad. 130 people are said to have been cured of AIDS to date. All of these people are under supervision now and regularly undergo medical examinations. The results obtained so far have been re-assuring, with no virus found in any case.
The Armenicum project, named after the medication of the same name, was launched by a team headed by Dr. Levon Gevorkyan, an honorary doctor of the Armenian National Academy of Sciences.
World Health Organization (WHO) members states display considerable interest to Armenicum - Armenian drug for treatment of AIDS, as said by Vahan Poghosyan, Head of Organization of Medical Aid Department of RA Healthcare Ministry on press conference. In his words, the drug was officially presented to the international community during the 57 conference of WHO held in 16-23 May in Switzerland, mentioning that the participants displayed active interest to the drug and they expect reactions in the nearest future.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsFuture of HIV cure research points to combination approach
The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published…
25 September 2015
NewsTargeting HIV in semen to shut down AIDS
There may be two new ways to fight AIDS - using a heat shock protein or a small molecule - to attack fibrils in semen associated with the human immunodeficiency virus (HIV) during the initial phases of infection,…
19 August 2015
NewsBreastfeeding could reduce common infections among Indigenous infants
Promoting breastfeeding could lead to a substantial reduction in common infections and even deaths that are more common in Indigenous infants than non-Indigenous infants, a new study suggests. Indigenous infants in…
18 August 2015

